世界のイムノアッセイ（免疫測定）市場：酵素、蛍光、化学発光、放射免疫測定...市場調査レポートについてご紹介

1 Introduction (Page No. – 30)
1.1 Key Take-Aways
1.2 Report Description
1.3 Research Methodology
1.3.1 Secondary Sources
1.3.2 Primary Sources
1.3.3 Market Size Estimation
1.3.4 Market Share
1.3.5 Key Data Points From Secondary Sources
1.3.6 Key Data Points From Primary Sources
1.3.7 Assumptions
1.4 Markets Covered
1.5 Stakeholders
1.6 Market Scope

2 Executive Summary (Page No. – 45)

3 Premium Insights (Page No. – 48)
3.1 Immunoassay Market Vs Other IVD Market Segments
3.2 Geographic Analysis, By Country
3.3 Applications Market
3.4 End-User Analysis
3.5 Competitive Analysis

4 Industry Analysis & Market Overview (Page No. – 54)
4.1 Introduction
4.2 Evolution
4.3 Market Segmentation
4.4 Market Dynamics
4.4.1 Drivers
4.4.1.1 Rising Incidence Of Chronic And Infectious Diseases In Emerging Economies To Drive The Immunoassay Market
4.4.1.2 Rapidly Aging Population Will Result In Increasing Chronic Diseases
4.4.1.3 Growing Popularity Of Portable Immunoassay To Stimulate Growth
4.4.1.4 Novel Biomarkers And Innovative Technologies To Give An Edge To Immunoassay Companies
4.4.1.5 Sensitive, Cost-Effective, & Rapidness Of Immunoassay Increases Adoption Rates
4.4.1.6 Increasing Health Awareness Responsible For The Growth Of The Immunoassay Market
4.4.2 Restraints
4.4.2.1 Low Detection Limits Restrict Adoption Of Immunoassay Tests
4.4.2.2 Lack Of Budget To Restrict Growth
4.4.3 Opportunities
4.4.3.1 New Range Of Condition-Specific Markers And Tests With Advances In Genomics And Proteomics
4.4.3.2 Increasing Adoption In Emerging Markets Such As China And India Are Creating Growth Opportunities For The Immunoassay Market
4.4.4 Threats
4.4.4.1 Pricing Pressure For Some Tests Due To Competition From Lower Cost-Per-Test Technologies
4.4.4.2 Stringent Regulatory Framework Acts As A Major Challenge
4.5 Burning Issues
4.5.1 Lateral Flow Immunoassay
4.5.1.1 Demand For LF Tests On The Rise
4.5.2 Laboratory Automation For Increased Efficiency And Accurate Diagnosis
4.6 Techniques To Validate New Biomarkers Using Immunoassay
4.7 Regulations
4.7.1 U.S.
4.7.2 Europe
4.7.3 Japan
4.7.4 China
4.7.5 India
4.8 Reimbursement Scenario & Challenges
4.9 Value Chain Analysis
4.10 Porter’s Analysis
4.10.1 Threat From New Entrants
4.10.2 Threat From Substitutes
4.10.3 Bargaining Power Of Buyers
4.10.4 Bargaining Power Of Suppliers
4.10.5 Competitive Rivalry Among Existing Players
4.11 Pestel Analysis
4.11.1 Political
4.11.2 Economic
4.11.3 Socio-Cultural
4.11.4 Technological
4.11.5 Environmental
4.11.6 Legal
4.12 Market Share Analysis
4.12.1 Global
4.12.2 Americas
4.12.3 Europe
4.12.4 Asia-Pacific

5 Immunoassay Market, By Technology (Page No. – 86)
5.1 Introduction
5.2 Enzyme Immunoassay (EIA)
5.2.1 EIA Is The Most Preferred Technique In The Immunoassay Market
5.3 Fluorescence Immunoassay (FIA)
5.3.1 Sensitivity Along With Low Cost Of FIA Drives The Market
5.4 Chemiluminescence Immunoassay (CLIA)
5.4.1 High Sensitivity, Automation & Wide Applications Of CLIA Responsible For The Highest Growth
5.5 Radioimmunoassays (RIA)
5.5.1 Despite Wide Applications & High Sensitivity, RIA To Lose Share To Safer Technologies Like EIA & CLIA
5.6 Others [Nephelometry, Turbidimetry, & Counting Immunoassay (CIA)]
5.6.1 Nephelometry Will Grow At A Meager Pace Due To Lack Of Major Advancements
5.6.2 Turbidometry & CIA To Grow At A Decent Rate
5.7 The Immunoassay Market Vs. Other IVD Segments
5.7.1 Immunoassay Contribute The Highest To IVD Market; Molecular Diagnostics Segment Will Grow The Fastest

6 Immunoassay Market, By Products (Analyzers & Reagents) (Page No. – 118)
6.1 Introduction
6.1.1 Reagents Market To Grow With Increase In Test Volumes
6.2 Analyzers
6.2.1 Medium-Throughput Analyzers Contribute The Highest To The Analyzers Revenue
6.2.2 High-Throughput Analyzers
6.2.2.1 High Throughput Analyzers Will Witness The Fastest Growth
6.2.3 Medium-Throughput Analyzers
6.2.4 Low-Throughput Analyzers
6.3 Reagents
6.3.1 Home Brew Assays Are Subject To Lenient Regulations

7 Immunoassay Market, By Application (Page No. – 132)
7.1 Introduction
7.2 Oncology
7.2.1 Oncology Biomarkers Can Help Early Detection Of Cancers
7.3 Endocrinology
7.3.1 Endocrinology Segment Will Be Driven By Increasing Incidences Of Diabetes & Thyroid Disorders
7.4 Bone & Mineral
7.4.1 Increasing Prevalence Of Bone & Mineral Disorders To Propel The Immunoassay Market
7.5 Cardiology
7.5.1 Immunoassay Techniques Are Frequently Used For Diagnosis Of Cardiac Ailments
7.5.2 Troponin Is The Most Preferred Biomarker In Cardiology
7.6 Infectious Diseases
7.6.1 Increasing Investments In The Infectious Diseases Due To High-Share, High-Growth Rate Nature Of The Segment
7.7 Hematology
7.8 Autoimmunity
7.8.1 Autoimmunity Segment Provides Significant Growth Opportunities To Immunoassay Players
7.9 Toxicology
7.9.1 Increasing Drug-Abuse Cases To Boost Immunoassay Toxicology Market
7.10 Neonatal Screening
7.10.1 Novel Biomarkers Identified For Newborn Screening In Public Health Practices
7.11 Others (Allergy, Stool Testing, & Serology)

8 Global Immunoassay Market, By End-Users (Page No. – 161)
8.1 Introduction
8.2 Hospitals (Private/Public)
8.2.1 Hospitals As End-Users Is A High Growth Rate, High Market Size Segment
8.3 Laboratories (Private/Public)
8.3.1 Laboratories Offer Various Advantages Over Hospitals Yet Will Grow At Lower Rate Due To Smaller Volumes
8.4 Academics
8.5 Pharmaceutical Industry, Cros, & Biotechs
8.5.1 Increasing Research Activities To Drive The Industrial Segment
8.6 Others (Physicians’ Offices, Blood Banks, Patient Self-Testing, & Ambulatory Centers)
8.6.1 The Demand For PST Is On A Rise

9 Geographic Analysis (Page No. – 169)
9.1 Introduction
9.1.1 U.S. The Major Contributor To Immunoassay Owing To Technological Advancements & Government Support
9.1.2 Asian And Latam Countries Offer Huge Opportunities To Investors
9.2 The Americas
9.2.1 U.S.
9.2.1.1 PPACA Has A Positive Impact On Immunoassay Business
9.2.1.2 Despite Unfavorable Conditions Key Players Look To Consolidate Their Business In U.S.
9.2.2 Canada
9.2.3 Mexico
9.2.3.1 Government Regulations & Reforms Support The Growth Of Immunoassay In Mexico
9.2.4 Brazil
9.2.4.1 Healthcare Reforms, Government Initiatives & Rise Of Infectious Diseases To Drive The Brazilian Immunoassay Market
9.2.5 Rest Of Americas (ROA)
9.3 Europe
9.3.1 Europe Immunoassay Market Will Grow At A Slow Pace Due To Decreased Funding & Strict Regulatory Guidelines
9.3.2 Germany
9.3.2.1 Germany To Grow At A High Pace Due To Presence Of Defined Outsourcing Chain Of Laboratory Services & Government Support
9.3.3 France
9.3.3.1 France Is The Second Biggest Immunoassay Market In Europe
9.3.4 Italy
9.3.4.1 Italy Will Grow At A Decent Pace Despite Various Challenges
9.3.5 Spain
9.3.5.1 Spain To Grow At A Meager Pace Due To Budget Cuts And Late Payments
9.3.6 U.K.
9.3.6.1 U.K.To Grow At The Fastest Rate In Europe Despite Roadblocks
9.3.7 Rest Of Europe (ROE)
9.4 Asia-Pacific
9.4.1 Japan
9.4.1.1 Japanese Immunoassay Market To Grow The Slowest In Asia Due To Regulatory Issues & Diagnostic Lag
9.4.2 India
9.4.2.1 Large Population Base, Increased Affordability & Government Initiatives Drive The Indian Immunoassay Market
9.4.3 China
9.4.3.1 China Will Be The Fastest Growing Immunoassay Market, Globally
9.4.4 South Korea
9.4.4.1 South Korea To Witness Double-Digit Growth In The Immunoassay Arena
9.4.5 Taiwan
9.4.5.1 Taiwan To Grow At Brisk Pace In The Immunoassay Business
9.4.6 ROAP
9.5 Rest Of The World (ROW)

10 Competitive Landscape (Page No. – 262)
10.1 Introduction
10.1.1 Agreements, Partnerships & JVS Is The Key Growth Strategy Adopted By Players
10.2 Agreements, Partnerships, Collaborations, & Joint Ventures
10.3 New Product Launches
10.4 Mergers & Acquisitions
10.5 Other Developments

11 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments) * (Page No. – 270)
11.1 Abbott Laboratories, Inc.
11.2 Alere, Inc.
11.3 Becton, Dickinson And Company
11.4 Biomérieux
11.5 Danaher Corporation (Beckman Coulter)
11.6 Diasorin S.P.A
11.7 Diasource Immunoassays S.A.
11.8 DRG International, Inc.
11.9 Hologic (Gen-Probe )
11.10 IBL International GMBH
11.11 IDS Plc
11.12 Meridian Life Science, Inc.
11.13 Ortho Clinical Diagnostics (A J&J Company)
11.14 Qiagen N.V.
11.15 Roche Diagnostics Limited
11.16 Siemens Healthcare
11.17 Sysmex Corporation
11.18 Thermo Fisher Scientific, Inc. (Brahms)